Literature DB >> 19171212

Fundus autofluorescence and progression of age-related macular degeneration.

Steffen Schmitz-Valckenberg1, Monika Fleckenstein, Hendrik P N Scholl, Frank G Holz.   

Abstract

Fundus autofluorescence imaging is an imaging method that provides additional information compared to conventional imaging techniques. It permits to topographically map lipofuscin distribution of the retinal pigment epithelial cell monolayer. Excessive accumulation of lipofuscin granules in the lysosomal compartment of retinal pigment epithelium cells represents a common downstream pathogenetic pathway in various hereditary and complex retinal diseases including age-related macular degeneration (AMD). This comprehensive review contains an introduction in fundus autofluorescence imaging, including basic considerations, the origin of the signal, different imaging methods, and a brief overview of fundus autofluorescence findings in normal subjects. Furthermore, it summarizes cross-sectional and longitudinal fundus autofluorescence findings in patients with AMD, addresses the pathophysiological significance of increased fundus autofluorescence, and characterizes different fundus autofluorescence phenotypes as well as fundus autofluorescence alterations with disease progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171212     DOI: 10.1016/j.survophthal.2008.10.004

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  55 in total

1.  [Imaging diagostics of geographic atrophy].

Authors:  M Fleckenstein; U Wolf-Schnurrbusch; S Wolf; C von Strachwitz; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

2.  Macular pigment density at the site of altered fundus autofluorescence.

Authors:  Simon Paul Rothenbuehler; Ute E K Wolf-Schnurrbusch; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-28       Impact factor: 3.117

3.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

4.  Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration.

Authors:  Pravin U Dugel; Roger L Novack; Karl G Csaky; Preston P Richmond; David G Birch; Ryo Kubota
Journal:  Retina       Date:  2015-06       Impact factor: 4.256

5.  Autophagy and KRT8/keratin 8 protect degeneration of retinal pigment epithelium under oxidative stress.

Authors:  Ahruem Baek; Soojin Yoon; Jean Kim; Yu Mi Baek; Hanna Park; Daehan Lim; Hyewon Chung; Dong-Eun Kim
Journal:  Autophagy       Date:  2017-01-03       Impact factor: 16.016

6.  [Vogt-Koyanagi-Harada Syndrome : An unusual case with lacquer crack-like retinal findings].

Authors:  M Parlak; G Kocaoglu; A O Saatci
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

7.  The Evolution of the Plateau, an Optical Coherence Tomography Signature Seen in Geographic Atrophy.

Authors:  Anna C S Tan; Polina Astroz; Kunal K Dansingani; Jason S Slakter; Lawrence A Yannuzzi; Christine A Curcio; K Bailey Freund
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

8.  Anti-SPARC oligopeptide inhibits laser-induced CNV in mice.

Authors:  Hironori Uehara; Ling Luo; Jacquelyn Simonis; Nirbhai Singh; Ethan Will Taylor; Balamurali K Ambati
Journal:  Vision Res       Date:  2009-12-22       Impact factor: 1.886

9.  Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domain-optical coherence tomography findings.

Authors:  Daniel V Vasconcelos-Santos; Elliott H Sohn; Srinivas Sadda; Narsing A Rao
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

10.  Single doses of all-trans-N-retinylacetamide slow down the ERG amplitude recovery after bleaching in rats.

Authors:  Andre Messias; Eberhart Zrenner; Radouil Tzekov; David McGee; Tobias Peters; Barbara Wilhelm; Aneta Baryluk; Ryo Kubota; Florian Gekeler
Journal:  Doc Ophthalmol       Date:  2009-12-11       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.